Mechanistically, LOXL1-AS1 competitively bond to miR-28-5p, resulting in upregulation of RAP1B. Additionally, in vivo study confirmed the findings discovered in vitro. CONCLUSIONS In summary, LOXL1-AS1 exerted oncogenic roles in EC progression by sponging miR-28-5p and thereby upregulating RAP1B. This finding might provide potential targets for EC therapy. PURPOSE Paroxysmal Permeability Disorders (PPDs) comprise a variety of diseases characterized by recurrent and transitory increase of endothelial permeability. Idiopathic Systemic Capillary Leak Syndrome (ISCLS) is a rare PPD that leads to an abrupt massive shift of fluids and proteins from the intravascular to the interstitial compartment. In some cases, tissue edema may involve the myocardium, but its role in the development of shock has not been elucidated so far. MATERIALS AND METHODS Assessment of cardiac involvement during ten life-threatening ISCLS episodes admitted to ICU. RESULTS Transthoracic echocardiographic examination was performed in eight episodes, whereas a poor acoustic window prevented cardiac ultrasound assessment in two episodes. Myocardial edema was detected by echocardiography in eight episodes and marked pericardial effusion in one-episode. Cardiac magnetic resonance showed diffuse myocardial edema in another episode. In one case, myocardial edema caused fulminant left ventricular dysfunction, which required extracorporeal life support. The mean septum thickness was higher during the shock phase compared to the recovery phase [15.5 mm (13.1-21 mm) vs. 9.9 mm (9-11.3 mm), p = .0003]. Myocardial edema resolved within 72 h. CONCLUSIONS During early phases of ISCLS, myocardial edema commonly occurs and can induce transient myocardial dysfunction, potentially contributing to the pathogenesis of shock. Age prediction of biological samples is one of the important tasks in forensic DNA phenotyping, and DNA methylation is regarded as the most promising biomarker for forensic age prediction. To date, numerous CpG sites have been reported to be age-related based on the changes in methylation. In this study, seven age-related CpG (AR-CpG) sites, cg02228185 (ASPA), cg09809672 (EDARADD), cg19283806 (CCDC102B), cg04208403 (ZNF423), chr17 44,390,358 of GRCh38/hg38 (ITGA2B), cg14361627 (KLF14), and cg06639320 (FHL2), were selected and analyzed in 310 blood samples using a multiplex methylation SNaPshot assay to evaluate the value of selected AR-CpGs in age prediction in blood from Chinese Han population. The study confirmed the correlation of all the investigated markers with human age, and the correlation of cg19283806 with age is the highest while cg04208403 is the lowest in the Chinese Han population. Two different age prediction models, stepwise regression and support vector regression (SVR), were established based on the methylation SNaPshot data using 230 blood samples from donors aged 2-86 years old.  https://www.selleckchem.com/products/bindarit.html  The stepwise regression model included six AR-CpGs (except cg09809672) and enabled age prediction with R2 = 0.85, mean absolute deviation (MAD) = 4.22, while the SVR model enabled age prediction with R2 = 0.86, MAD = 4.01. An independent set of 80 samples was used to test the two models' performance and the prediction MAD for the validation set was 4.71 and 4.56 for the stepwise regression and SVR models, respectively. The number of correct predictions for ±5 years achieved a high level of 67.50 % and 73.75 %, respectively for the stepwise regression and SVR models. In general, the SVR model was superior to the linear regression model in age prediction. These results suggest that these seven CpG sites would be useful for age prediction in blood samples from the Chinese Han population. The application of Bonferroni correction (BC) has been constantly controversial; nevertheless, in forensic population genetics research, it is common to apply it to Hardy-Weinberg equilibrium (HWE) tests referring to multiple loci. This letter aimed to discuss the problems of applying BC to HWE tests involving multiple loci by surveying population genetics research studies published over the last 10 years (2009-2019) from two major forensic genetic journals Forensic Science International Genetics (FSIG) and the International Journal of Legal Medicine (IJLM). The results showed that there was no uniform standard of whether to apply BC to HWE tests or not, and researchers commonly did not provide any explanation for the observation of deviations from HWE. Despite its widespread use in population genetics, BC may not guarantee a prudent result due to an irrelevant null hypothesis, reluctance to reject the null hypothesis, different interpretations of identical p-values, and inflated type Ⅱ error. We recommended a notable two-step approach suggested by Waples to evaluate the results of HWE tests 1) identifying causes of departures from HWE and 2) evaluating the biological consequences of HW departures. In addition, for forensic researchers, we suggested that if a certain degree of deviation from HWE does occur, the first step to take should involve checking the technique and genotyping results carefully rather than recklessly using BC. In conclusion, according to the purpose of forensic population research, applying BC to HWE tests is unnecessary; rather, an unadjusted α should be used. BC does not "rescue" the deviation from HWE. To "rescue" it indeed, directly discussing the possible explanation for each departure from HWE and simply describing what has been done sequentially and why should be enough for readers to reach a reasonable conclusion even without the help of Bonferroni methods. Colon carcinoma is a recurring type of cancer that affects the intestine epithelial with a poor survival rate. It was already proven the anticancer property of hesperidin in various cancers but the bioavailability hesperidin is poor, which hinders the hesperidin usage. In this investigation we synthesized hesperidin loaded Zn2+@ SA/PCT nanocomposites and assessed its anticancer potential against colon cancer (HCT116) cells. Hesperidin loaded Zn2+@ SA/PCT nanocomposites were characterized using Fourier transform infrared (FTIR), X-ray diffraction (XRD), scanning electron microscope (SEM) and transmission electron microscope (TEM) analysis. The drug releasing capacity and cytotoxic property was assessed via drug releasing assay, MTT assay with HCT116 cells. The anticancer potency of hesperidin nanocomposites were evaluated with TUNEL, DAPI staining, reactive oxygen species (ROS) generation assay and it is confirmed with flow cytometry analysis of MMP disruption in colon cancer (HCT116) cell line. Further the immunoblotting analysis of cysteine proteases Caspases 3, 9, PARP, proapoptotic protein Bax and antiapoptotic protein Bcl2 were performed.